ACA Will Survive Repeal Efforts, But As “Health Reform 1.0,” Experts Predict
Executive Summary
Over the next two years, the Affordable Care Act will mainly survive challenges in the courts, Congress and the states, Project HOPE’s Gail Wilensky and Henry Aaron of the Brookings Institution predicted during a policy conference in Washington, D.C. March 8.
You may also be interested in...
FTC Early Findings In PBM Investigation Coming By Mid-Summer, Chair Khan Says
The agency is also poised to announce another development in its scrutiny of the drug patents listed in the FDA’s Orange Book.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.